Skip to main content
Top
Published in: Strahlentherapie und Onkologie 7/2012

01-07-2012 | Original article

Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases

Authors: R.A. Bundschuh, N. Andratschke, J. Dinges, M.N. Duma, S.T. Astner, M. Brügel, S.I. Ziegler, M. Molls, M. Schwaiger, M. Essler

Published in: Strahlentherapie und Onkologie | Issue 7/2012

Login to get access

Abstract

Purpose

The use of 4D-[18F]fluorodeoxyglucose (FDG) PET/CT in combination with respiratory gated magnet resonance imaging (MRI) in target volume definition for stereotactic radiation of liver metastases was investigated.

Methods and materials

A total of 18 patients received respiration gated FDG-PET/CT and MRI. Data were fused using a rigid co-registration algorithm. The quality of the co-registration was rated on a scale from 1 (excellent) to 5 (poor) for co-registration of MRI with gated PET and ungated PET. Gross tumor volume (GTV) was delineated in CT (GTV CT), MRI (GTVMRI), and PET (GTVPET). MRI- and PET-based GTVs were defined by three observers each. Interobserver variability was calculated for all patients as well as for subgroups with and without previous treatment of liver metastases. All GTVs were compared for all patients and separately for patients with previous local therapy. In addition, a semiautomatic segmentation algorithm was applied on the PET images.

Results

Co-registration  between MR and PET images was rated with 3.3 in average when non-gated PET was used and improved significantly (p < 0.01) to 2.1 using gated PET. The average GTVCT  was 51.5 ml, GTVMRI  51.8 ml, and the average GTVPET  48.1 ml. Volumes delineated in MRI were 9.9% larger compared to those delineated in CT. Volumes delineated in PET were 13.8% larger than in MRI. The differences between the GTVs were more pronounced in patients with previous treatment. The GTVs defined in MRI showed an interobserver variability of 47.9% (84.1% with previous treatment and 26.2% without previous treatment). The PET-defined GTVs showed an interobserver variability of 21% regardless of previous treatment. Semiautomatic segmentation did not provide satisfying results.

Conclusion

FDG-PET can distinguish vital tumor tissue and scar tissue, and therefore alters the GTV especially in patients with previous local treatment. In addition, it reduces the interobserver variability significantly compared to MRI. However, respiratory gated PET is necessary for good co-registration of PET and MRI.
Literature
1.
go back to reference Lammering G, De Ruysscher D, Baardwijk A van et al (2010) The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol 186:471–481PubMedCrossRef Lammering G, De Ruysscher D, Baardwijk A van et al (2010) The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol 186:471–481PubMedCrossRef
2.
go back to reference Gilbeau L, Octave-Prignot M, Loncol T et al (2001) Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiother Oncol 58:155–162PubMedCrossRef Gilbeau L, Octave-Prignot M, Loncol T et al (2001) Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiother Oncol 58:155–162PubMedCrossRef
3.
go back to reference Wel A van Der, Nijsten S, Hochstenbag M et al (2005) Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61:649–655CrossRef Wel A van Der, Nijsten S, Hochstenbag M et al (2005) Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61:649–655CrossRef
4.
go back to reference Nestle U, Schaefer-Schuler A, Kremp S et al (2007) Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:453–462PubMedCrossRef Nestle U, Schaefer-Schuler A, Kremp S et al (2007) Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:453–462PubMedCrossRef
5.
go back to reference De Ruysscher D, Kirsch CM (2010) PET scans in radiotherapy planning of lung cancer. Radiother Oncol 96:335–338CrossRef De Ruysscher D, Kirsch CM (2010) PET scans in radiotherapy planning of lung cancer. Radiother Oncol 96:335–338CrossRef
6.
go back to reference Astner ST, Dobrei-Ciuchendea M, Essler M et al (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72:1161–1167PubMedCrossRef Astner ST, Dobrei-Ciuchendea M, Essler M et al (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72:1161–1167PubMedCrossRef
7.
go back to reference Astner ST, Bundschuh RA, Beer AJ et al (2009) Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography. Int J Radiat Oncol Biol Phys 73:1135–1140PubMedCrossRef Astner ST, Bundschuh RA, Beer AJ et al (2009) Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography. Int J Radiat Oncol Biol Phys 73:1135–1140PubMedCrossRef
8.
go back to reference Daisne JF, Duprez T, Weynand B et al (2004) Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233:93–100PubMedCrossRef Daisne JF, Duprez T, Weynand B et al (2004) Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233:93–100PubMedCrossRef
9.
go back to reference Eich HT, Muller RP, Engenhart-Cabillic R et al (2008) Involved-node radiotherapy in early-stage Hodgkin’s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184:406–410PubMedCrossRef Eich HT, Muller RP, Engenhart-Cabillic R et al (2008) Involved-node radiotherapy in early-stage Hodgkin’s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184:406–410PubMedCrossRef
10.
go back to reference Girinsky T, Ghalibafian M, Bonniaud G et al (2007) Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85:178–186PubMedCrossRef Girinsky T, Ghalibafian M, Bonniaud G et al (2007) Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85:178–186PubMedCrossRef
11.
go back to reference Erdi YE, Mawlawi O, Larson SM et al (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505–2509PubMedCrossRef Erdi YE, Mawlawi O, Larson SM et al (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505–2509PubMedCrossRef
12.
go back to reference Bayne M, Hicks RJ, Everitt S et al (2010) Reproducibility of “intelligent” contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. Int J Radiat Oncol Biol Phys 77:1151–1157PubMedCrossRef Bayne M, Hicks RJ, Everitt S et al (2010) Reproducibility of “intelligent” contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. Int J Radiat Oncol Biol Phys 77:1151–1157PubMedCrossRef
13.
go back to reference Oshiro Y, Aruga T, Tsuboi K et al (2010) Stereotactic body radiotherapy for lung tumors at the pulmonary hilum. Strahlenther Onkol 186:274–279PubMedCrossRef Oshiro Y, Aruga T, Tsuboi K et al (2010) Stereotactic body radiotherapy for lung tumors at the pulmonary hilum. Strahlenther Onkol 186:274–279PubMedCrossRef
14.
go back to reference Holy R, Piroth M, Pinkawa M et al (2011) Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 187:245–251PubMedCrossRef Holy R, Piroth M, Pinkawa M et al (2011) Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 187:245–251PubMedCrossRef
15.
go back to reference Astner ST, Theodorou M, Dobrei-Ciuchendea M et al (2010) Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningiomas. Strahlenther Onkol 186:423–429PubMedCrossRef Astner ST, Theodorou M, Dobrei-Ciuchendea M et al (2010) Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningiomas. Strahlenther Onkol 186:423–429PubMedCrossRef
16.
go back to reference Pech M, Mohnike K, Wieners G et al (2008) Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol 184:256–261PubMedCrossRef Pech M, Mohnike K, Wieners G et al (2008) Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol 184:256–261PubMedCrossRef
17.
go back to reference Geets X, Lee JA, Bol A et al (2007) A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 34:1427–1438PubMedCrossRef Geets X, Lee JA, Bol A et al (2007) A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 34:1427–1438PubMedCrossRef
18.
go back to reference Brandner ED, Wu A, Chen H et al (2006) Abdominal organ motion measured using 4D CT. Int J Radiat Oncol Biol Phys 65:554–560PubMedCrossRef Brandner ED, Wu A, Chen H et al (2006) Abdominal organ motion measured using 4D CT. Int J Radiat Oncol Biol Phys 65:554–560PubMedCrossRef
19.
go back to reference Nehmeh SA, Erdi YE, Ling CC et al (2002) Effects of respiratory gating on quantifying PET images of lung cancer. J Nucl Med 43:876–881PubMed Nehmeh SA, Erdi YE, Ling CC et al (2002) Effects of respiratory gating on quantifying PET images of lung cancer. J Nucl Med 43:876–881PubMed
20.
go back to reference Visvikis D, Barret O, Fryer TD et al (2004) Evaluation of respiratory motion effects in comparison with other parameters affecting PET image quality. IEEE Nucl Sci Symp Visvikis D, Barret O, Fryer TD et al (2004) Evaluation of respiratory motion effects in comparison with other parameters affecting PET image quality. IEEE Nucl Sci Symp
21.
go back to reference Delso G, Ziegler S (2009) PET/MRI system design. Eur J Nucl Med Mol Imaging 36(Suppl 1):86–92CrossRef Delso G, Ziegler S (2009) PET/MRI system design. Eur J Nucl Med Mol Imaging 36(Suppl 1):86–92CrossRef
22.
go back to reference Krengli M, Milia ME, Turri L et al (2010) FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol 5:10PubMedCrossRef Krengli M, Milia ME, Turri L et al (2010) FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol 5:10PubMedCrossRef
23.
go back to reference Bassi MC, Turri L, Sacchetti G et al (2008) FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 70:1423–1426PubMedCrossRef Bassi MC, Turri L, Sacchetti G et al (2008) FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 70:1423–1426PubMedCrossRef
Metadata
Title
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases
Authors
R.A. Bundschuh
N. Andratschke
J. Dinges
M.N. Duma
S.T. Astner
M. Brügel
S.I. Ziegler
M. Molls
M. Schwaiger
M. Essler
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Strahlentherapie und Onkologie / Issue 7/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-012-0094-3

Other articles of this Issue 7/2012

Strahlentherapie und Onkologie 7/2012 Go to the issue